Myelin and Lymphocyte-Associated Proteolipid Proteins
"Myelin and Lymphocyte-Associated Proteolipid Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of MARVEL domain-containing proteolipid proteins involved in vesicular trafficking cycling between the GOLGI COMPLEX and the apical PLASMA MEMBRANE.
| Descriptor ID |
D062806
|
| MeSH Number(s) |
D10.570.780.249 D12.776.543.488.374 D12.776.543.620.264 D12.776.543.990.681 D12.776.631.580.249 D12.776.816.249
|
| Concept/Terms |
Myelin and Lymphocyte-Associated Protein- Myelin and Lymphocyte-Associated Protein
- Myelin and Lymphocyte Associated Protein
- T-Lymphocyte Maturation Associated Protein
- T Lymphocyte Maturation Associated Protein
- MAL Proteolipid
- MAL Protein, T-cell
- MAL Protein, T cell
- T-cell MAL Protein
|
Below are MeSH descriptors whose meaning is more general than "Myelin and Lymphocyte-Associated Proteolipid Proteins".
Below are MeSH descriptors whose meaning is more specific than "Myelin and Lymphocyte-Associated Proteolipid Proteins".
This graph shows the total number of publications written about "Myelin and Lymphocyte-Associated Proteolipid Proteins" by people in this website by year, and whether "Myelin and Lymphocyte-Associated Proteolipid Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Myelin and Lymphocyte-Associated Proteolipid Proteins" by people in Profiles.
-
Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue. PLoS Pathog. 2019 03; 15(3):e1007500.
-
MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma. Biomed Pharmacother. 2018 Sep; 105:1072-1078.